Similar articles

• [Diabetes mellitus and hypertension: calcium antagonists or ACE inhibitors?].

  Jungmann E. Jungmann E. Dtsch Med Wochenschr. 1991 May 31;116(22):859-62. doi: 10.1055/s-2008-1063690. Dtsch Med Wochenschr. 1991. PMID: 2036945 Review. German. No abstract available.
• Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study.

  Rejnmark L, Vestergaard P, Mosekilde L. Rejnmark L, et al. J Hypertens. 2006 Mar;24(3):581-9. doi: 10.1097/01.hjh.0000203845.26690.cb. J Hypertens. 2006. PMID: 16467662 Clinical Trial.
• [Evolution of myocardial ischemia therapy: calcium antagonists and ACE-inhibitors].

  Ferrari R. Ferrari R. Cardiologia. 1994 Dec;39(12 Suppl 1):203-6. Cardiologia. 1994. PMID: 7634268 Italian.
• Use of calcium channel blockers and angiotensin-converting enzyme inhibitors after cardiac transplantation.

  Rockx MA, Haddad H. Rockx MA, et al. Curr Opin Cardiol. 2007 Mar;22(2):128-32. doi: 10.1097/HCO.0b013e3280210681. Curr Opin Cardiol. 2007. PMID: 17284992 Review.
• Trough-to-peak ratio of angiotensin converting enzyme inhibitors and calcium antagonists.

  Myers MG. Myers MG. Am J Hypertens. 1997 May;10(5 Pt 1):580-2. Am J Hypertens. 1997. PMID: 9160773 No abstract available.